Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget’s disease of bone
Science Advances · 2023
DOI: 10.1126/sciadv.ade6998 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Xiangxiang Hu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Oral and Craniofacial Biomedicine Program, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Hauptthemen laut MEDLINE: Osteitis Deformans. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS.
Abstract (Originalsprache)
Degenerative diseases affecting the nervous and skeletal systems affect the health of millions of elderly people. Optineurin (OPTN) has been associated with numerous neurodegenerative diseases and Paget’s disease of bone (PDB), a degenerative bone disease initiated by hyperactive osteoclastogenesis. In this study, we found age-related increase in OPTN and nuclear factor E2-related factor 2 (NRF2) in vivo. At the molecular level, OPTN could directly interact with both NRF2 and its negative regulator Kelch-like ECH-associated protein 1 (KEAP1) for up-regulating antioxidant response. At the cellular level, deletion of OPTN resulted in increased intracellular reactive oxygen species and increased osteoclastogenic potential. At the tissue level, deletion of OPTN resulted in substantially increased oxidative stress derived from leukocytes that further stimulate osteoclastogenesis. Last, curcumin attenuated hyperactive osteoclastogenesis induced by OPTN deficiency in aged mice. Collectively, our findings reveal an OPTN-NRF2 axis maintaining bone homeostasis and suggest that antioxidants have therapeutic potential for PDB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Oral and Craniofacial Biomedicine Program, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- Division of Oral and Craniofacial Health Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- Division of Orthodontics, The Ohio State University College of Dentistry, Columbus, OH 43210, USA.
- Division of Comprehensive Oral Health, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Hangz…
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.
ORCID-Profile: Xiangxiang Hu, Sing-Wai Wong, Kaixin Liang, Tai-Hsien Wu, Lufei Wang, Jie Liu, Brian L Foster, Jenny P-Y Ting, Baohong Zhao, Henry C Tseng, Ching-Chang Ko
Förderung
- NIDCR NIH HHS
Zitieren
APA
Hu, X., Wong, S. W., Liang, K., Wu, T. H., Wang, S., Wang, L., Liu, J., Yamauchi, M., Foster, B. L., Ting, J. P., Zhao, B., Tseng, H. C., & Ko, C. C. (2023). Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget’s disease of bone. Science Advances. https://doi.org/10.1126/sciadv.ade6998
Vancouver
Hu X, Wong SW, Liang K, Wu TH, Wang S, Wang L, et al. Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget’s disease of bone. Science Advances. 2023. doi:10.1126/sciadv.ade6998
BibTeX
@article{Hu2023,
author = {Hu, Xiangxiang and Wong, Sing-Wai and Liang, Kaixin and Wu, Tai-Hsien and Wang, Sheng and Wang, Lufei and Liu, Jie and Yamauchi, Mitsuo and Foster, Brian L and Ting, Jenny P-Y and Zhao, Baohong and Tseng, Henry C and Ko, Ching-Chang},
title = {Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget’s disease of bone},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.ade6998}
}
EUVIMED